Current Status and Future Perspectives on the Internet of Things in Oncology.

Journal: Hematology/oncology and stem cell therapy
Published Date:

Abstract

The Internet of Things (IoT) has penetrated many aspects of everyday human life. The use of IoT in healthcare has been expanding over the past few years. In this review, we highlighted the current applications of IoT in the medical literature, along with the challenges and opportunities. IoT use mainly involves sensors and wearables, with potential applications in improving the quality of life, personal health monitoring, and diagnosis of diseases. Our literature review highlights that the current main application studied in the literature is physical activity tracking. In addition, we discuss the current technologies that would help IoT-enabled devices achieve safe, quick, and meaningful data transfer. These technologies include machine learning/artificial intelligence, 5G, and blockchain. Data on current IoT-enabled devices are still limited, and future research should address these devices' effect on patients' outcomes and the methods by which their integration in healthcare will avoid increasing costs.

Authors

  • Ibrahim N Muhsen
    Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
  • Omar W Rasheed
    College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Eiad A Habib
    College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Rakan K Alsaad
    College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Mohannad K Maghrabi
    College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Md A Rahman
    Department of Cyber Security and Forensic Computing, University of Prince Mugrin, Medina, Saudi Arabia.
  • Douglas Sicker
    School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, USA.
  • William A Wood
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Muhammad S Beg
    Division of Hematology/Medical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Anthony D Sung
    Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, NC, USA.
  • Shahrukh K Hashmi
    Department of Medicine, Mayo Clinic, Rochester, MN, USA.